BFS
PLRX icon

Bare Financial Services’s Pliant Therapeutics PLRX Stock Holding History

Bare Financial Services’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-413
Closed -$504 – 1850
2025
Q4 		$504 Buy
+413
New +$620 ﹤0.01% 1389

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Bare Financial Services's PLRX Position: Q1 2026 in Review

Bare Financial Services sold out of Pliant Therapeutics (PLRX) in Q1 2026, closing a stake of 413 shares — an estimated $504 sold.

Bare Financial Services first reported a position in PLRX in Q4 2025 and held it in 1 quarter. The position peaked at $504 in Q4 2025. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Bare Financial Services reported no remaining Pliant Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bare Financial Services sold 413 Pliant Therapeutics shares in Q1 2026, an estimated $504.
  • Bare Financial Services first reported a position in Pliant Therapeutics in Q4 2025 and held it in 1 quarter.
  • Bare Financial Services's Pliant Therapeutics position peaked at $504 in Q4 2025.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Bare Financial Services's 13F filing for Q1 2026, filed 14 May 2026.